Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Winning Health Technology Group Co., Ltd. (300253.SZ)
CNY7.09
+0.26 (+3.81%)
CN SHZ Healthcare Medical - Healthcare Information Services
Address
99 Shouyang Road 200072
Shanghai, CN
Shanghai, CN
CEO
Tao Wang
Website
winning.com.cn
IPO
2011-08-19
ISIN CNE1000016F5
Description
Winning Health Technology Group Co., Ltd. specializes in delivering comprehensive information technology solutions to hospitals and various medical service organizations throughout China. Their services cover the entire lifecycle of IT provision, from initial design, planning, and strategic consulting to development, system deployment, ongoing maintenance, and operational management. These advanced solutions are instrumental in establishing intelligent hospital environments, as well as powering regional, community, and public healthcare oversight platforms, medical insurance systems, and a broad spectrum of other health services. Founded in Shanghai, China, in 1994, the company was initially known as Shanghai Kingstar Winning Software Co., Ltd. before officially adopting its current name in January 2016.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY7.09
+0.26 (+3.81%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
63M
Beta
0.48
Float Shares
1.68B
Free Float %
76.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.85% | -9.15% | -9.26% | -27.14% | -8.62% | -11.11% | -17.91% | -19.26% | -52.63% | -9.05% | +4,821.22% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
7.09
DCF (Unlevered)
0.61
-91.4%
DCF (Levered)
0.62
-91.2%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
4.84
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Healthcare Information Services: +14.2%-24.3% Q1'26: +15.2% (vs Q1'25)
-
EPS growth Medical - Healthcare Information Services: +43.1%-517.7% Q1'26: +166.7% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%+0.4% Q1'26: -20.0% (vs Q1'25)
-
EBIT margin Medical - Healthcare Information Services: +8.8%-17.8% Q1'26: -4.8% (vs Q1'25)
-
ROIC Medical - Healthcare Information Services: +5.2%-7.5% Q1'26: -0.9% (vs Q1'25)
-
Share dilution Medical - Healthcare Information Services: -0.1%+1.9% Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-7.65× Q1'26: -15.69× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
753.16M
est: 783.00M (-3.8%)
|
954.47M
est: 1.07B (-10.4%)
|
1.20B
est: 1.23B (-2.1%)
|
1.44B
est: 1.54B (-6.6%)
|
1.91B
est: 1.92B (-0.5%)
|
2.27B
est: 2.42B (-6.3%)
|
2.75B
est: 2.88B (-4.5%)
|
3.09B
est: 3.11B (-0.6%)
|
3.16B
est: 3.20B (-1.0%)
|
2.78B
est: 3.41B (-18.4%)
|
2.11B
est: 2.51B (-16.0%)
|
2.40B
2.33B – 2.45B
-4.2% YoY
|
2.73B
2.56B – 2.83B
+13.5% YoY
|
3.09B
3.09B – 3.09B
+13.3% YoY
|
| EBITDA |
110.97M
est: 93.03M (+19.3%)
|
154.70M
est: 126.54M (+22.2%)
|
274.53M
est: 146.08M (+87.9%)
|
372.23M
est: 183.07M (+103.3%)
|
409.03M
est: 227.82M (+79.5%)
|
495.70M
est: 287.31M (+72.5%)
|
299.20M
est: 342.35M (-12.6%)
|
90.90M
est: 369.62M (-75.4%)
|
417.06M
est: 195.14M (+113.7%)
|
293.17M
est: 208.19M (+40.8%)
|
-147.50M
est: 153.11M (-196.3%)
|
146.71M
142.24M – 149.81M
-4.2% YoY
|
166.46M
156.34M – 172.71M
+13.5% YoY
|
188.55M
188.55M – 188.55M
+13.3% YoY
|
| EBIT |
101.87M
est: 87.18M (+16.9%)
|
145.23M
est: 118.57M (+22.5%)
|
259.83M
est: 136.88M (+89.8%)
|
356.35M
est: 171.54M (+107.7%)
|
391.29M
est: 213.48M (+83.3%)
|
477.18M
est: 269.21M (+77.3%)
|
279.34M
est: 320.79M (-12.9%)
|
69.54M
est: 346.34M (-79.9%)
|
395.28M
est: 107.77M (+266.8%)
|
270.25M
est: 114.97M (+135.1%)
|
-373.88M
est: 84.55M (-542.2%)
|
81.02M
78.55M – 82.73M
-4.2% YoY
|
91.93M
86.34M – 95.38M
+13.5% YoY
|
104.12M
104.12M – 104.12M
+13.3% YoY
|
| Net Income |
152.50M
est: 193.60M (-21.2%)
|
518.62M
est: 559.56M (-7.3%)
|
229.04M
est: 249.19M (-8.1%)
|
303.31M
est: 332.24M (-8.7%)
|
398.42M
est: 413.49M (-3.6%)
|
491.10M
est: 505.96M (-2.9%)
|
378.17M
est: 523.69M (-27.8%)
|
108.64M
est: 184.64M (-41.2%)
|
357.96M
est: 371.54M (-3.7%)
|
87.89M
est: 457.05M (-80.8%)
|
-373.88M
est: 174.11M (-314.7%)
|
56.67M
44.00M – 66.00M
-67.5% YoY
|
176.16M
132.02M – 220.04M
+210.9% YoY
|
299.42M
176.03M – 396.07M
+70.0% YoY
|
| SGA |
268.55M
est: 164.33M (+63.4%)
|
316.01M
est: 223.51M (+41.4%)
|
271.49M
est: 258.02M (+5.2%)
|
318.92M
est: 323.35M (-1.4%)
|
381.90M
est: 402.40M (-5.1%)
|
464.12M
est: 507.47M (-8.5%)
|
585.95M
est: 604.68M (-3.1%)
|
707.67M
est: 652.86M (+8.4%)
|
653.83M
est: 607.24M (+7.7%)
|
545.37M
est: 647.83M (-15.8%)
|
222.48M
est: 476.43M (-53.3%)
|
456.54M
442.60M – 466.17M
-4.2% YoY
|
517.99M
486.50M – 537.43M
+13.5% YoY
|
586.72M
586.72M – 586.72M
+13.3% YoY
|
| EPS |
0.08
est: 0.09 (-10.2%)
|
0.26
est: 0.26 (+0.3%)
|
0.11
est: 0.12 (-4.7%)
|
0.15
est: 0.15 (-2.5%)
|
0.19
est: 0.19 (-0.8%)
|
0.23
est: 0.23 (-1.8%)
|
0.18
est: 0.24 (-25.8%)
|
0.05
est: 0.09 (-40.5%)
|
0.17
est: 0.17 (-1.7%)
|
0.04
est: 0.21 (-80.5%)
|
-0.17
est: 0.08 (-312.5%)
|
0.03
0.02 – 0.03
-66.7% YoY
|
0.08
0.06 – 0.10
+200.0% YoY
|
0.13
0.08 – 0.18
+66.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-26 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-25 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-19 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-18 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-15 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-14 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-13 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-12 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-11 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-08 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-07 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-06 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
261.58M
OE per share TTM
0.12
Owner's Yield
1.52%
Maintenance CapEx ratio
154.32%
Maint CapEx / Avg PPE
19.1%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 34 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | VanEck ChiNext ETF CNXT | 0.19% | 229.2K | 0.65% |
| 2 | State Street SPDR S&P China ETF GXC | 0.02% | 98.1K | 0.59% |
| 3 | State Street SPDR S&P Emerging Asia Pacific ETF GMF | 0.02% | 71.5K | 0.49% |
| 4 | Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF EMCR | 0.01% | 5.2K | 0.15% |
| 5 | Franklin FTSE China ETF FLCH | 0.01% | 20.8K | 0.19% |
| 6 | Franklin FTSE China UCITS ETF FLXC.L | 0.01% | 89.1K | 0.19% |
| 7 | Goldman Sachs MarketBeta Emerging Markets Equity ETF GSEE | 0.01% | 7.1K | 0.45% |
| 8 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 16.8K | 0.44% |
| 9 | Vanguard FTSE Asia ex Japan Shares Index ETF VAE.AX | 0.00% | 14.2K | 0.40% |
| 10 | State Street SPDR Portfolio Emerging Markets ETF SPEM | 0.00% | 377.6K | 0.07% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-65.8K
Shares Outstanding
2.20B
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jia Ming Sun | Senior Vice President | — | male |
| Li Wang | Chief Financial Officer | — | male |
| Mao Jin | Senior Vice President & Director | — | male |
| Tao Wang | GM & Director | — | male |
| Zitong Xu | Senior Vice President & Secretary of the Board of Directors | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300253.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
